Home
overview

SMi is proud to announce the return of their 13th annual Controlled Release event to London in 2016! Controlled-release (CR) drug-delivery systems continue to play an important role in the treatment of diseases.

With an increase prevalence of cancer globally and advanced developments in controlled release technologies, controlled release remains the top priority for formulation scientists. Recent breakthroughs include the utilisation of nanotechnology and hydrogel polymers in controlled release mechanisms. In particular a long-acting insulin analogue shows promise for the treatment of diabetes, a unique approach which activates a micelle formation, facilitating transport of drug and significantly increasing absorption with a 10 to 50 fold increase in bioavailability.*

SMi’s 13th Controlled Release 2016 event will engage you in lively discussions with industry leaders to discover the latest innovations, as well as guiding you through the latest regulatory updates to ensure strict compliance. Through the 2-day meeting, you will learn about up and coming novel controlled release strategies to accelerate commercialisation.

*http://www.pharmtech.com/oral-absorption-enhancing-drug-delivery-technology


 


• Discuss the latest innovations surrounding controlled release with case studies from GlaxoSmithKline, Ipsen and Merck
• Gain key regulatory updates from MHRA talking specifically on grey areas such as the regulatory environment surrounding combination products 
• Join insightful discussions on nanotechnology from AstraZeneca and  in depth discussions on QbD from UCB Pharma and Novo Nordisk 
• Engage in our interactive sessions and speed networking to solidify your learning experience amongst your peers

 

You should attend this event if you are a Director, Area Head, Chief Executive, CSO, or Vice President within the pharmaceutical or healthcare industry with responsibilities in the following areas:


• Controlled release
• Drug delivery systems
• Analytical development
• Formulation development
• Pharmaceutical sciences
• Preclinical development
• Toxicology
• PK/PD
• Process development
• Regulatory affairs
• R&D
• Nanoparticles
• Software
 

Past Attendees include:

3m Healthcare; Boehringer Ingelheim Pharma GmbH & Co.; Callum Consultancy; Novartis; Johnson & Johnson; Ceylon Petroleum Corporation; Critical Pharmaceuticals Limited; Evonik; Ferring; GlaxoSmithKline; Hoffmann-La Roche Inc; Imperial College London; Ipsen Research Laboratories; Italfarmaco; Kings College London; McNeil Consumer Specialty and Pharmaceuticals; MHRA; Novartis Pharmaceuticals; P C A S; Pharmacircle; SiTec PharmaBio; University of Nottingham and many more!

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Howard Stevens

Howard Stevens Professor, University Of Strathclyde

9:10 MHRA: Supporting innovation in controlled release and combination products

Marion Westwood

Marion Westwood Pharmaceutical Assesor, MHRA

  • Discuss the latest innovations surrounding controlled release
  • Gain key regulatory updates from leading competent authorities talking specifically on grey areas such as the regulatory environment surrounding combination products
  • Case study on work with OxSonics.
     
  • 9:50 An industrial perspective on novel oral dose controlled release technologies

    Mark Wilson

    Mark Wilson Director Platform Technology and Science , GlaxoSmithKline

  • GSK’s activities to develop new platform drug delivery technologies
  • Approaches to collaboration and partnering with external organisations
  • The application and implementation of new technologies within GSK
     
  •          

    10:30 Morning Coffee

    11:00 Examining how Quality by Design (QbD) can aid formulation and controlled release delivery

    David Elder

    David Elder Externalisation Director, GlaxoSmithKline

  • Assessing the importance of QbD in controlled release delivery
  • Implementation of QbD principles in the development of microsponges as drug delivery carriers
  • The advantages of implementing QbD into controlled release systems
  • 11:40 Application of Quality-by-Design during spray drying scale-up

    Sune Andersen

    Sune Andersen Principal Scientist Drying Processes, Novo Nordisk A / S

  • Examining the use of spray drying in controlled release
  • Linking lab-scale QbD with production scale QbD
  • Scale-up impact on solid dosage forms
  • 12:20 Networking Lunch

    13:50 Regulatory perspective on innovative systems for controlled release

    Mohammad  Absar

    Mohammad Absar Pharmacologist, FDA

    · An overview of current innovative controlled release systems in the US market
    · Scientific and regulatory challenges in developing generic controlled release systems
    · FDA/OGD’s ongoing research program
     

    14:30 Controlling peptide stability to unlock their therapeutic potential

    Saif Shubber

    Saif Shubber Formualtion Scientist, MedImmune Inc.

  • Peptides as pharmaceutical drugs
  • Challenges to their formulation and delivery
  • Overcoming the challenges; Formulation development & drug delivery
  • Future directions and conclusions
     
  • 15:10 Afternoon Tea

    15:40 How are combination products altering the drug delivery landscape?

    Howard Stevens

    Howard Stevens Professor, University Of Strathclyde

  • Current issues with the combination of drugs with different release mechanisms
  • The regulatory environment surrounding combination products with different controlled release mechanisms
  • Who can support you with regulatory compliance?
  • 16:20 The importance of controlled release in nanomedicine design

    Marianne Ashford

    Marianne Ashford Principal Scientist Drug Targeting, AstraZeneca

  •  Predicting modelling for nanomedicine design
  • Optimising drug release from a nanomedicine to improve therapeutic index
  • Comparison of different nanomedicines in improving therapeutic index
  • Case studies and data sharing
     
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    David Elder

    David Elder Externalisation Director, GlaxoSmithKline

    9:10 The future of controlled release peptide drug delivery

    Andy Lewis

    Andy Lewis Director Novel Drug Delivery Technologies, Ipsen

  • How to incorporate imagining techniques into the R&D stage of controlled release drug delivery
  • Discussing the application of molecular imaging techniques to enhance the development and optimisation of controlled release systems
  • An analysis of the current molecular imaging techniques on the market
     
     
  • 9:50 Microfluidics & drug delivery systems for controlled release: production, characterisation and industrial translation

    Dario Carugo

    Dario Carugo Research Fellow, University of Oxford & University of Southhampton

  • Production of nanoscale and microscale drug delivery vehicles using microfluidic technology
  • Development of acoustofluidic platforms for ultrasound-mediated intracellular delivery of therapeutic compounds
  • Biomimetic microfluidic architectures to investigate drug release processes within physiologically-relevant microenvironments
  • Industrial translation of microfluidic technology: challenges and future perspectives
  • 10:30 Morning Coffee

    11:00 Dissolution testing: A key tool for a better product design

    Samir Haddouchi

    Samir Haddouchi Managing Director, SPS Pharma Services

  • Principles of dissolution
  • How does dissolution relate to Biopharmaceutical Classification System (BCS) and  In Vitro/In Vivo Correlation (IVIVC)
  • API characterisation and dissolution
  • Case studies
  • 11:40 Parenteral controlled release: revival for increased adherence

    Sachin Mittal

    Sachin Mittal Senior Principal Scientist, Merck

  • Parenteral Controlled Release and Adherence
  • Development of parenteral controlled release dosage forms: Design and Manufacture
  • Understanding the Performance of Controlled Release dosage forms
     
  •  

    12:20 Networking Lunch

    13:50 How to formulate poorly soluble drugs

    Rene Holm

    Rene Holm Senior Director, H Lundbeck A/S

  • Available pharmaceutical technologies for formulating low sol compounds
  • Technical and biopharmaceutical considerations of the technologies
  • Future trends in the formulation of low soluble compounds
     
  • 14:30 Multi-particulates – formulation factors and challenges during development and transfer

    Inder Gulati

    Inder Gulati Formulation R&D Lead, Merck

  • Advantage of Multi-unit particulate dosage form over single unit dosage form
  • Formulation components for Multi-unit particulate system (MUPS)
  • Equipment for manufacturing of MUPS
  • Process transfer for MUPS
     
  • 15:10 Afternoon Tea

    15:40 CriticalMix platform technology: a novel platform technology for sustained delivery of small and large API’s

    Anjumn Shabir-Ahmed

    Anjumn Shabir-Ahmed Head of Pharmaceutical Science , Critical Pharmaceuticals Limited

  •  Overview of who Critcal Pharmaceuticals are
  • Issues with current technologies surrounding microparticles for API’s of all sizes
  • Overview and advantages of the CriticalMix process
  • Case studies
     
     
  • 16:20 Selection and development of controlled release technology suitable for adult and paediatric dosing

    Harpreet  Sandhu

    Harpreet Sandhu Senior Director, Kashiv Pharma

  • Multiparticulate controlled release formulations are well known for providing superior controlled release compare to the monolithic systems due to lower food effect and uniform gastric emptying.
  • The advantages of multiparticulate system was further extended to maximize the dosing flexibility during development for adult and paediatric dosing
  • Product development including the selection of technology, release mechanism, and development of IVIVR/IVIVC will be discussed 
  •  

     

    17:00 Optimising drug delivery systems to mimic the human circadian rhythm

    Daniel Margetson

    Daniel Margetson Director CMC, Diurnal

  • The influence of circadian rhythm on human physiological systems and disease state
  • Optimising drug release to reflect the natural human circadian cycle
  • Controlled release therapies for circadian therapeutic areas of interest: Chronocort®- a case study
  • +

    FEATURED SPEAKERS

    Andy Lewis

    Andy Lewis

    Director Novel Drug Delivery Technologies, Ipsen
    Marianne Ashford

    Marianne Ashford

    Principal Scientist Drug Targeting, AstraZeneca
    Marion Westwood

    Marion Westwood

    Pharmaceutical Assesor, MHRA
    Mark Wilson

    Mark Wilson

    Director Platform Technology and Science , GlaxoSmithKline
    Sachin Mittal

    Sachin Mittal

    Senior Principal Scientist, Merck
    Sune Andersen

    Sune Andersen

    Principal Scientist Drying Processes, Novo Nordisk A / S

    Andy Lewis

    Director Novel Drug Delivery Technologies, Ipsen
    Andy Lewis

    Anjumn Shabir-Ahmed

    Head of Pharmaceutical Science , Critical Pharmaceuticals Limited
    Anjumn Shabir-Ahmed

    Daniel Margetson

    Director CMC, Diurnal
    Daniel Margetson

    Dario Carugo

    Research Fellow, University of Oxford & University of Southhampton
    Dario Carugo

    David Elder

    Externalisation Director, GlaxoSmithKline
    David Elder

    Harpreet Sandhu

    Senior Director, Kashiv Pharma
    Harpreet  Sandhu

    Howard Stevens

    Professor, University Of Strathclyde
    Howard Stevens

    Inder Gulati

    Formulation R&D Lead, Merck
    Inder Gulati

    Jerome Mantanus

    Senior Scientist QbD/PAT Drug Product Formulation, UCB Pharma
    Jerome Mantanus

    Marianne Ashford

    Principal Scientist Drug Targeting, AstraZeneca
    Marianne Ashford

    Marion Westwood

    Pharmaceutical Assesor, MHRA
    Marion Westwood

    Mark Wilson

    Director Platform Technology and Science , GlaxoSmithKline
    Mark Wilson

    Mohammad Absar

    Pharmacologist, FDA
    Mohammad  Absar

    Rene Holm

    Senior Director, H Lundbeck A/S
    Rene Holm

    Sachin Mittal

    Senior Principal Scientist, Merck
    Sachin Mittal

    Saif Shubber

    Formualtion Scientist, MedImmune Inc.
    Saif Shubber

    Samir Haddouchi

    Managing Director, SPS Pharma Services
    Samir Haddouchi

    Sune Andersen

    Principal Scientist Drying Processes, Novo Nordisk A / S
    Sune Andersen

    Sponsors and Exhibitors

    Supporters

    ASSOCIATED EVENTS

    QbD/PAT Driven Controlled Release Design and Development
    Workshop

    QbD/PAT Driven Controlled Release Design and Development

    Holiday Inn Regents Park
    20th April 2016
    London, United Kingdom

    Exploring Controlled Release Drug Delivery Methods
    Workshop

    Exploring Controlled Release Drug Delivery Methods

    Holiday Inn Regents Park
    20th April 2016
    London, United Kingdom

    VENUE

    Holiday Inn Regents Park

    Carburton Street, London, London, United Kingdom

    Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes.

    Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames.

    Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.

    HOTEL BOOKING FORM

    Controlled Release Interview with the MHRA

    Download

    Controlled Release Interview with Kashiv Pharma

    Download

    Controlled Release Interview with Merck

    Download

    Sponsors


    Sotax

    Sponsors and Exhibitors
    http://www.sotax.com

    SOTAX is a global leader in providing innovative solutions for pharmaceutical testing. The company offers high-quality dissolution testing systems, physical tablet testing instruments, automated sample preparation workstations for composite assay and content uniformity testing, as well as associated technical and application services.

    Media Partners


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    American Pharmaceutical Review is the leading review of business and technology for the pharmaceutical industry throughout North America. Each issue offers unbiased editorial on drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. American Pharmaceutical keeps its 30,000 readers including senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.


    Antibodies Online

    Supporters
    http://www.antibodies-online.com

    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit Biocompare to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. Visit: www.biocompare.com


    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    International Journal of Biomedical Nanoscience and Nanotechnology

    Supporters
    http://www.inderscience.com/ijbnn

    IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.


    International Journal of Biotechnology

    Supporters
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    International Journal of Computational Biology and Drug Design

    Supporters
    http://www.inderscience.com/ijcbdd

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


    International Journal of Nano and Biomaterials

    Supporters
    http://www.inderscience.com/ijnbm

    In recent years, frontiers of research in engineering, science and technology have been driven by developments in nanomaterials, encompassing a diverse range of disciplines such as materials science, biomedical engineering, nanomedicine and biology, manufacturing technology, biotechnology, nanotechnology, and nanoelectronics. IJNBM provides an interdisciplinary vehicle covering these fields. Advanced materials inspired by biological systems and processes are likely to influence the development of novel technologies for a wide variety of applications from vaccines to artificial tissues and organs to quantum computers.


    International Journal of Nanoparticles

    Supporters
    http://www.inderscience.com/ijnp

    Nanoparticles are becoming key components in a wide range of applications. Research encompasses numerous disciplines, e.g. nanotechnology, molecular engineering, medicine, pharmaceutical drug manufacture, biology, chemistry, physics, optical components, polymer science, mechanical engineering, toxicology, cosmetics, energy, food technology and environmental and health sciences. IJNP highlights the chemical, physical and biological phenomena/processes associated with nanoparticles and nanostructures ranging from molecular size to 100nm which exhibit improved properties or have novel applications due to their size. Submicron nanoparticles are included in special cases.


    International Journal of Nanotechnology

    Supporters
    http://www.inderscience.com/ijnt

    IJNT offers a multidisciplinary source of information in all subjects and topics related to Nanotechnology, with fundamental, technological, as well as societal and educational perspectives. Special issues are regularly devoted to research and development of nanotechnology in individual countries and on specific topics. Articles for IJNT are by invitation only.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Lab Bulletin

    Supporters
    http://www.labbulletin.com

    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Pharmatching.com

    Supporters
    http://pharmatching.com

    Pharmatching.com is an efficient, targeted and easy-to-use-“Web2.0”-tool for finding the right partners in the pharmaceutical industry worldwide. It saves time and costs in all (out)sourcing and business development processes, as it fascilitates and accelerates the searching process for appropriate business partners significantly. Pharmatching.com is particularly advantageous for projects where a special service is (immediately) required or to offer capacities which are currently available. It is useful for services in all categories and stages of drug development including contract manufacturing, contract research, laboratory investigations, contractual testing, non-clinical and clinical research, active pharmaceutical ingredients, consulting, marketing, registration, in- and outlicensing etc.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Regents Park

    Carburton Street
    London W1W 5EE
    United Kingdom

    Holiday Inn Regents Park

    Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes.

    Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames.

    Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, United Kingdom, Link to Map
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.